Spires‐Jones, Tara L.

Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease

Tzioras, M., Davies, C., Newman, A., Jackson, R., & Spires‐Jones, T. (2019) · Neuropathology and Applied Neurobiology

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 147

Differential effect of three‐repeat and four‐repeat tau on mitochondrial axonal transport

Stoothoff, W., Jones, P. B., Spires‐Jones, T. L., Joyner, D., Chhabra, E., Bercury, K., Fan, Z., Xie, H., Bacskai, B., Edd, J., et al. (2009) · Journal of Neurochemistry

Alzheimer's disease research and treatmentsAmyotrophic Lateral Sclerosis Research

Cited by 135

Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity

Wegmann, S., Maury, E. A., Kirk, M. J., Saqran, L., Roe, A., DeVos, S. L., Nicholls, S., Fan, Z., Takeda, S., Cagsal‐Getkin, O., et al. (2015) · The EMBO Journal

Alzheimer's disease research and treatmentsPrion Diseases and Protein Misfolding

Cited by 132

Evaluation of [ 3 H]SynVesT‐1 binding parameters in post‐mortem brain tissue from control and Alzheimer's Disease

Lemoine, L., Kulagowska, L., Bonsall, D., King, D., Gladstein, S., Bevis, A., Sabandal, M., Wells, L., Finnema, S. J., Spires‐Jones, T. L., et al. (2025) · Alzheimer's & Dementia

Alzheimer's disease research and treatmentsNeuroscience and Neuropharmacology Research

Cited by 1

Using high‐resolution array tomography to validate the use of synaptic vesicle glycoprotein 2A as a biomarker for synaptic loss in Alzheimer's disease

Young, L., King, D., Chang, Y. Y., Holt, K., Gladstein, S., Finnema, S. J., & Spires‐Jones, T. L. (2025) · Alzheimer's & Dementia

Alzheimer's disease research and treatmentsNeuroscience and Neuropharmacology Research

Cited by 1